Literature DB >> 3652895

Carbohydrate malabsorption is minimal in school-age cystic fibrosis children.

R D Hoffman1, J N Isenberg, G K Powell.   

Abstract

Fifteen school-age cystic fibrosis children, participating in a year-long nutritional management study, were hospitalized at six-month intervals for balance studies during which they continued "free-choice" diets and their usual enzyme supplementation. Stools were analyzed for fat and protein by conventional methods and for carbohydrate using a recently validated anthrone method. Despite persistent fat and protein malabsorption, less than 1% of ingested carbohydrate was lost intact in the stools. Comparison of baseline and placebo balance studies showed fecal excretion of carbohydrate to be independent of intake, in contrast to the fat and protein results. Using a thin-layer chromatography method capable of detecting microgram quantities of urinary organic acids, no short-chain fatty acids were detected in the stool. Further exploration of carbohydrate as a dietary energy source for this patient group with increased energy demands should be pursued.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652895     DOI: 10.1007/BF01300190

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  A study of conditions for Kjeldahl determination of nitrogen in proteins; description of methods with mercury as catalyst, and titrimetric and gasometric measurements of the ammonia formed.

Authors:  A HILLER; J PLAZIN; D D VAN SLYKE
Journal:  J Biol Chem       Date:  1948-12       Impact factor: 5.157

2.  Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.

Authors:  A Lapey; J Kattwinkel; P A Di Sant'Agnese; L Laster
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

3.  A simple screening method for detecting isovalerylglycine in urine patients with isovaleric acidemia.

Authors:  T Ando; W L Nyhan
Journal:  Clin Chem       Date:  1970-05       Impact factor: 8.327

Review 4.  Gastrointestinal manifestations of cystic fibrosis: a review.

Authors:  R W Park; R J Grand
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

5.  Incomplete absorption of the carbohydrate in all-purpose wheat flour.

Authors:  I H Anderson; A S Levine; M D Levitt
Journal:  N Engl J Med       Date:  1981-04-09       Impact factor: 91.245

6.  A simple spectrophotometric method for quantitative fecal carbohydrate measurement.

Authors:  V Z Ameen; G K Powell
Journal:  Clin Chim Acta       Date:  1985-10-31       Impact factor: 3.786

7.  Passage of carbohydrate into the colon. Direct measurements in humans.

Authors:  A M Stephen; A C Haddad; S F Phillips
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

8.  The effect of cimetidine on maldigestion in cystic fibrosis.

Authors:  K L Cox; J N Isenberg; A B Osher; R R Dooley
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

9.  Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

Authors:  P R Durie; L Bell; W Linton; M L Corey; G G Forstner
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

10.  One-step quantitative extraction of medium-chain and long-chain fatty acids from aqueous samples.

Authors:  M Cohen; R G Morgan; A F Hofmann
Journal:  J Lipid Res       Date:  1969-09       Impact factor: 5.922

View more
  3 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Drug therapies for reducing gastric acidity in people with cystic fibrosis.

Authors:  Sze May Ng; Helen S Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

3.  Drug therapies for reducing gastric acidity in people with cystic fibrosis.

Authors:  Sze May Ng; Helen S Moore
Journal:  Cochrane Database Syst Rev       Date:  2021-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.